Galderma Group AG (GALD) Price & Analysis

Compare

8 Followers

GALD Stock Chart & Stats

Day’s Range― - ―

52-Week RangeCHF67.02 - CHF138.80

Previous CloseN/A

Volume230.69K

Average Volume (3M)1.04M

Market Cap

CHF30.29B

Enterprise ValueCHF29.23B

Total Cash (Recent Filing)CHF457.00M

Total Debt (Recent Filing)CHF2.76B

Price to Earnings (P/E)92.3

Beta0.97

Next Earnings

Mar 05, 2026

EPS Estimate

1.31

Last Dividend Ex-Date

Apr 25, 2025

Dividend Yield0.12%

Share Statistics

EPS (TTM)1.11

Shares Outstanding237,897,630

10 Day Avg. Volume2,322,492

30 Day Avg. Volume1,040,724

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF138.30

Price Target Upside8.47% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering12

Bulls Say, Bears Say

Bulls Say

Market PerformanceGalderma continues to outperform peers in the aesthetics and skincare markets despite the US consumer spending slowdown.

Product PerformanceNemluvio is expected to reach $4.8bn peak sales with faster market share gain than anticipated in rapidly growing markets.

Bears Say

Consumer ExpenditureThe mid-term forecasts remain below consensus for both aesthetics and dermatological skincare, reflecting a cautious outlook on consumer expenditure and price pressure in the fillers category.

Market EnvironmentContinued market softness in the US is met with intense promotional activity, affecting the overall market environment.

Galderma Group AG News

Galderma Group AG: Strong First Half Performance and Upgraded Sales Outlook Justify Buy Rating

Jefferies analyst Benjamin Jackson CFA maintained a Buy rating on Galderma Group AG today and set a price...

13d ago

Positive Outlook for Galderma Group AG Driven by Strong Nemluvio Prescription Growth and Upbeat Sales Forecast

In a report released today, Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG,...

19d ago

Strong Growth Prospects for Galderma Group AG Driven by Nemluvio’s Performance

Jefferies analyst Lucy Codrington has maintained their bullish stance on GALD stock, giving a Buy rating on July...

24d ago

Strong Market Performance and Growth Potential Drive Buy Rating for Galderma Group AG

Benjamin Jackson CFA, an analyst from Jefferies, maintained the Buy rating on Galderma Group AG (GALD – Research...

1M ago

Strong Future Prospects for Galderma Group AG: Buy Rating Supported by Product Uptake and Market Expansion Opportunities

Analyst Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG (GALD – Research Report)...

2M ago

Galderma Group AG’s Nemluvio Drives Strong Buy Rating Amid Impressive Prescription Growth

Galderma Group AG (GALD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst...

2M ago

Galderma Group AG: Promising Growth Prospects and Strategic Positioning Justify Buy Rating

Analyst Benjamin Jackson CFA of Jefferies maintained a Buy rating on Galderma Group AG (GALD – Research Report),...

3M ago

Cautious Outlook for Galderma Group AG Amid Strong Sales and Tariff Concerns

Analyst Thibault Boutherin from Morgan Stanley maintained a Hold rating on Galderma Group AG (GALD – Research Report)...

3M ago

Positive Indicators and Strong Performance Drive Buy Rating for Galderma Group AG

Galderma Group AG (GALD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst...

3M ago

Buy Recommendation for Galderma Group AG Amid Growth Opportunities and Resilience to Tariff Impacts

Jefferies analyst Benjamin Jackson CFA has maintained their bullish stance on GALD stock, giving a Buy rating today....

4M ago

GALD FAQ

What was Galderma Group AG’s price range in the past 12 months?

Galderma Group AG lowest stock price was CHF67.02 and its highest was CHF138.80 in the past 12 months.

What is Galderma Group AG’s market cap?

Galderma Group AG’s market cap is CHF30.29B.

When is Galderma Group AG’s upcoming earnings report date?

Galderma Group AG’s upcoming earnings report date is Mar 05, 2026 which is in 211 days.

How were Galderma Group AG’s earnings last quarter?

Galderma Group AG released its earnings results on Jul 24, 2025. The company reported CHF1.106 earnings per share for the quarter, beating the consensus estimate of CHF0.927 by CHF0.179.

Is Galderma Group AG overvalued?

According to Wall Street analysts Galderma Group AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Galderma Group AG pay dividends?

Galderma Group AG pays a Notavailable dividend of CHF0.15 which represents an annual dividend yield of 0.12%. See more information on Galderma Group AG dividends here

What is Galderma Group AG’s EPS estimate?

Galderma Group AG’s EPS estimate is 1.31.

How many shares outstanding does Galderma Group AG have?

Galderma Group AG has 237,897,630 shares outstanding.

What happened to Galderma Group AG’s price movement after its last earnings report?

Galderma Group AG reported an EPS of CHF1.106 in its last earnings report, beating expectations of CHF0.927. Following the earnings report the stock price went up 7.575%.

Which hedge fund is a major shareholder of Galderma Group AG?

Currently, no hedge funds are holding shares in CH:GALD

Company Description

Galderma Group AG

Galderma Group AG (GALD) is a global dermatology company specializing in the research, development, and commercialization of innovative medical solutions for the skin. The company operates across several sectors, including prescription drugs, aesthetics, and consumer care. Galderma offers a range of products that address various dermatological needs, such as acne, rosacea, psoriasis, and skin cancer, alongside aesthetic treatments like dermal fillers and botulinum toxins. Its comprehensive portfolio is designed to enhance the health, beauty, and quality of life of its customers.

Galderma Group AG (GALD) Earnings & Revenues

Historic Earnings Reports

GALD Stock 12 Month Forecast

Average Price Target

CHF138.30

▲(8.47% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"CHF76","121":"CHF121","166":"CHF166","98.5":"CHF98.5","143.5":"CHF143.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":165,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF165.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":138.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF138.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":112,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF112.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,98.5,121,143.5,166],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,130.3846153846154,133.26923076923077,136.15384615384616,139.03846153846155,141.92307692307693,144.80769230769232,147.69230769230768,150.57692307692307,153.46153846153845,156.34615384615384,159.23076923076923,162.1153846153846,{"y":165,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,128.33076923076922,129.16153846153847,129.9923076923077,130.82307692307694,131.65384615384616,132.48461538461538,133.31538461538463,134.14615384615385,134.97692307692307,135.80769230769232,136.63846153846154,137.4692307692308,{"y":138.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,126.3076923076923,125.11538461538461,123.92307692307692,122.73076923076923,121.53846153846153,120.34615384615384,119.15384615384616,117.96153846153847,116.76923076923077,115.57692307692308,114.38461538461539,113.1923076923077,{"y":112,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":80.76,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.48,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":81.3,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":89.41,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >